2^nd European Cardiology Congress

Biography

Biography: Syed Raza

Abstract

Antithrombotic therapy has revolutionized the medical management of patients. Over the past 20 years, the development of new antithrombotic medications and strategies has reduced ischemic events very significantly. With every approach to reduce thrombosis, however, there is an accompanying risk of increasing bleeding complications. Conversely, reducing bleeding complications may increase thrombotic (ischemic) events Due to increasing number of elderly populations, prevalence of thrombosis related complications and bleeding associated with anti -thrombotic treatment is constantly rising. There are various tools to assess thrombotic risk, but assessment of bleeding risk is often ignored Thrombosis and bleeding, both increase morbidity and mortality. Balancing both ends of the spectrum is essential, and an individualized approach to therapy is advocated. The author will present various strategies to balance the thrombotic and bleeding risk assessment and management. This presentation will be of interest to Physicians, Cardiologists, Haematologists, Surgeons, Anesthetists and nurses.